Form 4: Cencora EVP Verma Granted 3,963 Restricted Stock Units
Executive Equity Grant
Pawan Verma, Cencora's EVP, Chief Data & Info Officer, received a grant of 3,963 Restricted Stock Units, vesting in three equal annual installments.
Summary
- Pawan Verma, Executive Vice President, Chief Data & Information Officer of Cencora, Inc. (COR), was granted 3,963 Restricted Stock Units (RSUs).
- The RSUs were received for no consideration.
- These RSUs will vest in three equal installments on November 12, 2026, November 12, 2027, and November 12, 2028.
- Following this transaction, Pawan Verma beneficially owns 3,963 derivative securities (RSUs) directly.
Sentiment
Score: 6
Explanation: The filing reports a routine executive equity grant, which is a positive for aligning management and shareholder interests, but does not contain information that would significantly alter the company's overall sentiment.
Positives
- The grant of Restricted Stock Units aligns the executive's long-term interests with those of shareholders.
- Equity compensation is a standard practice to incentivize key management personnel.
Negatives
- No direct negatives are identified from this routine executive compensation filing.
Risks
- No specific risks related to the company's operations or financial health are disclosed in this Form 4 filing.
Future Outlook
The vesting schedule for the Restricted Stock Units indicates future equity ownership for the executive, aligning their long-term incentives with company performance over the next three years.
Industry Context
The grant of Restricted Stock Units to an executive is a common form of long-term incentive compensation across various industries, particularly in large publicly traded companies like Cencora, Inc., to attract, retain, and motivate key talent.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted practice, comparable to compensation structures seen at peer companies in the pharmaceutical and healthcare services distribution sector.
- The vesting schedule over three years is typical for long-term incentive plans, similar to those at companies like Cardinal Health (CAH) or McKesson Corporation (MCK), which also utilize equity grants to align executive and shareholder interests.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | The grant of Restricted Stock Units is part of the company's executive compensation framework, reflecting standard corporate governance practices for incentivizing key personnel. | 11/12/2025 | Aligns executive interests with long-term shareholder value. |
Related Party Transactions
- This filing reports an equity grant to an executive, which is a standard compensation arrangement and not typically classified as an unusual related-party transaction in this context.
Stakeholder Impact
- Shareholders: The grant aligns the executive's financial interests with long-term shareholder value creation.
- Employees: May signal stability in executive leadership and a commitment to long-term incentives.
Next Steps
- The Restricted Stock Units will vest in three equal annual installments on November 12, 2026, November 12, 2027, and November 12, 2028.
Key Dates
| Date | Description |
|---|---|
| 11/12/2025 | Date of RSU grant transaction. |
| 11/12/2026 | First vesting installment of Restricted Stock Units. |
| 11/12/2027 | Second vesting installment of Restricted Stock Units. |
| 11/12/2028 | Third and final vesting installment of Restricted Stock Units. |
Keywords
Cencora, COR, Restricted Stock Units, RSU, Pawan Verma, Executive Compensation, Insider Transaction, Equity Grant, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.